Abstract
Trauma-induced alterations in the endocannabinoid (eCB) system have been reported in animal models and few human studies of post-traumatic stress disorder (PTSD), but there is no consensus on the direction of these changes. Given the potential therapeutic use of cannabinoids in PTSD treatment, it is critical to understand the nature of the eCB system alterations in individuals with PTSD.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
